Education
About Us
Working with TipRanks
Follow Us
MIRA Pharmaceuticals, Inc. (MIRA)
:MIRA
MIRA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.51 - $5.01
Previous CloseN/A
Volume531.69K
Average Volume (3M)490.75K
Market Cap
N/A
Enterprise Value$94.80M
Total Cash (Recent Filing)$1.21M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.48
Shares Outstanding17,385,140
10 Day Avg. Volume170,775
30 Day Avg. Volume490,749
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)-158.77
Price to Sales (P/S)0.00
P/FCF Ratio-16.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-3.35
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MIRA Pharmaceuticals, Inc. News
PremiumCompany Announcements
MIRA Pharmaceuticals’ Ketamir-2 Published in Pharmacology Journal
PremiumCompany Announcements
MIRA Pharmaceuticals Joins BIO Convention for Strategic Opportunities
PremiumCompany Announcements
MIRA Pharmaceuticals Appoints New Chief Financial OfficerOptions Prices
Currently, No data available
---
Ownership Overview
25.25% Insiders
1.31% Mutual Funds
3.34% Other Institutional Investors
69.41% Public Companies and Individual Investors
MIRA FAQ
What was MIRA Pharmaceuticals, Inc.’s price range in the past 12 months?
MIRA Pharmaceuticals, Inc. lowest stock price was $0.51 and its highest was $5.01 in the past 12 months.
What is MIRA Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is MIRA Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MIRA Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is MIRA Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts MIRA Pharmaceuticals, Inc.’s price is currently Overvalued.
Does MIRA Pharmaceuticals, Inc. pay dividends?
MIRA Pharmaceuticals, Inc. does not currently pay dividends.
What is MIRA Pharmaceuticals, Inc.’s EPS estimate?
MIRA Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MIRA Pharmaceuticals, Inc. have?
MIRA Pharmaceuticals, Inc. has 17,385,140 shares outstanding.
What happened to MIRA Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MIRA Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in MIRA
Company Description
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Technical Analysis
Bristol-Myers Squibb
―
GlaxoSmithKline
―
Grifols SA
―
Scilex Holding Company
―
Citius Oncology
―